Reducing hallucinations in schizophrenia with focused ultrasound: First-in-human clinical trial begins

The Medical News · 1h ago

Auditory hallucinations – or hearing voices that others do not hear – affect more than 70% of people with schizophrenia. Despite treatment with antipsychotic medications, approximately 40% continue to experience persistent hallucinations. For these patients, new treatment approaches are urgently needed.

Read original article on The Medical News →

Reducing hallucinations in schizophrenia with focused ultrasound: First-in-human clinical trial begins

Related news